Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: Clvr - The Untold Story

Are Nasdaq-Traded Colombian Cannabis Stocks Worth Buying? Yes And No, Says Analyst

Cantor Fitzgerald's analyst Pablo Zuanic initiated coverage on two cannabis companies on Monday: Flora Growth Corp. (NASDAQ: FLGC) and Clever Leaves Holdings Inc (NASDAQ: CLVR)

3 Cannabis Stocks That Have Plunged More Than 55% in 2022

3 Cannabis Stocks That Have Plunged More Than 55% in 2022

The outlook for the cannabis industry is brightening due to the overwhelming demand for it to treat several diseases. However, the uncertainty surrounding the legalization of cannabis at the federal level, and renewed concerns related to the health implications of its use, have caused many companies to suffer a retreat.…

Clever Leaves Reports First Quarter 2022 Results: Revenue Increases 50% To $5.2M

Clever Leaves Reports First Quarter 2022 Results: Revenue Increases 50% To $5.2M

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids reported late Thursday its financial and operating results for the first quarter en

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Recap: Clever Leaves Holdings Q1 Earnings

Clever Leaves Holdings (NASDAQ:CLVR) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Clever Leaves Partners With Biom Therapeutics As Supplier Of Pharmaceutical-Grade CBD Used In Clinical Trials

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW), announced a two-year supply agreement with American, clinical-stage bio-pharmaceutical company, Biom Therapeutics to provide

Do Sundial Growers and Clever Leaves Deserve a Place in Your Cannabis Portfolio?

Cannabis stocks, such as Sundial Growers (SNDL) and Clever Leaves (CLVR), are trading significantly lower compared to record highs. While the two companies might look attractive to contrarian investors, you need to take a closer look at the financials to make a long-term investment decision.

34 Stocks Moving in Friday's Pre-Market Session

Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22 guidance.

inkl

Read news from The Economist, FT, and more,
with one subscription

A Preview Of Clever Leaves Holdings's Earnings

A Preview Of Clever Leaves Holdings's Earnings

Clever Leaves Holdings (NASDAQ:CLVR) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts estimate that Clever Leaves Holdings will report an earnings per share (EPS) of $-0.53.

Clever Leaves Teams Up With FoliuMed To Import Colombian Cannabis EU-GMP Bulk Extracts Into Germany

Clever Leaves Teams Up With FoliuMed To Import Colombian Cannabis EU-GMP Bulk Extracts Into Germany

Clever Leaves Holdings Inc. (NASDAQ: CLVR) has signed a one-year international sales agreement with German- Colombian operator FoliuMed Holdings and its German manufacturing partner, Fidelio Healthcare. With access to three of Clever Leaves’ pharmaceutical grade bulk cannabis extracts

Clever Leaves Inks $7.8M Product Deal With Australian Medical Cannabis Company

Clever Leaves Inks $7.8M Product Deal With Australian Medical Cannabis Company

Clever Leaves Holdings Inc. (NASDAQ: CLVR) has inked a four-year take or pay supply agreement with an Australian medicinal cannabis company, Australian Natural Therapeutics Group.

Clever Leaves Expands Partnership With German Cannabis Distributor Cansativa On Heels Of $15M Raise

Clever Leaves Expands Partnership With German Cannabis Distributor Cansativa On Heels Of $15M Raise

Clever Leaves Holdings Inc. (NASDAQ: CLVR) is expanding its partnership with German cannabis distributor and wholesaler Cansativa GmbH.

Clever Leaves' Pharmaceutical-Grade Cannabis Extracts Reach Germany Via Ethypharm Partnership

Clever Leaves' Pharmaceutical-Grade Cannabis Extracts Reach Germany Via Ethypharm Partnership

Pharmaceutical-grade cannabinoids extracts produced by Clever Leaves Holdings Inc. (NASDAQ: CLVR) will soon be available for distribution by its partner in Germany, Ethypharm GmbH, a European specialty pharmaceutical company.

Clever Leaves Expands Deal With Cannatrek In Australia Via $3.6M Sales Agreement To Include THC Flower

Clever Leaves Expands Deal With Cannatrek In Australia Via $3.6M Sales Agreement To Include THC Flower

Clever Leaves Holdings Inc. (NASDAQ: CLVR) announced an expansion of its relationship with Australian medical cannabis company Cannatrek Ltd. by signing a two-year, take-or-pay basis supply agreement.

Clever Leaves' Q4 Revenue Up 25% YoY, Introduces 2022 Outlook & New CEO

Clever Leaves' Q4 Revenue Up 25% YoY, Introduces 2022 Outlook & New CEO

Clever Leaves Holdings Inc. (NASDAQ: CLVR) reported its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2021, along with its 2022 outlook.

Get all your
news in one place.

100's of premium titles.
One news app.

Clever Leaves Enters US Consumer CBD Market Via Herbal Brands' JoySol

Clever Leaves Holdings Inc. (NASDAQ: CLVR), a multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced Wednesday that it has officially entered the U.S. CBD market through the launch of its consumer-oriented CBD line JoySol.

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Cantor Fitzgerald

Flora Growth Corp

Sundial Growers

Clever Leaves Holdings Inc

House Rules Committee

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

415,707 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play